why choose us

Clinical Trials Search

Showing 14,800 of 132,963 result(s)
Home Sleep Therapy for Older Adults With MCI

Status: Completed

Condition: Mild Cognitive Impairment

Interventions: Oscillating electrical current

Date: 2023-02-24

AT1001 for the Treatment of Long COVID

Status: Completed

Condition: Long COVID

Interventions: AT1001 (Larazotide) is a locally acting, non-systemic, octapeptide inhibitor of the zonulin receptor that has shown efficacy in a large variety of ani

Date: 2023-02-24

A Single-Session Intervention for Families on Waitlists for Child Anxiety Treatment

Status: Completed

Condition: Anxiety Disorders

Interventions: Single Session Intervention (SSI) module for youth with anxiety disorders and their parents.
The SSI module will include psychoeducation on the c

Date: 2023-02-24

An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias

Status: Completed

Condition: Immune Thrombocytopenia

Interventions: Administered by subcutaneous injection every 4 weeks

Date: 2023-02-24

Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

Status: Completed

Condition: Parkinson Disease

Interventions: Lenrispodun 30 mg tablets administered orally, once daily.

Date: 2023-02-24

Study of 18F-0502B PET Imaging Targeting ?-synuclein in the Diagnosis of ?-synuclein-related Diseases

Status: Completed

Condition: Positron-Emission Tomography

Interventions:

Date: 2023-02-24

Estimation of the Diaphragm Electrical Activity and Intercostal Thickening Fraction During Different Pattern of Mechanical Ventilation: PSV Versus NAVA

Status: Completed

Condition: Respiratory Failure

Interventions: intercostal thickening fraction values during PSV and NAVA modalities in patients with difficult weaning from MV admitted in ICU.

Date: 2023-02-24

Tranexamic Acid in Patients for Caesarian Delivery.

Status: COMPLETED

Condition: Postpartum Hemorrhage

Interventions: The intervention consists of administration of 1gm of Tranexamic acid (TXA) intravenously or 10-mls of placebo (normal saline) intravenously, slowly o

Date: 2023-02-24

High-dose Dual Therapy With Different Administration Frequencies

Status: Completed

Condition: Helicobacter Pylori Infection

Interventions: Proton pump inhibitor

Date: 2023-02-24

Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist

Status: COMPLETED

Condition: Moderate Asthma

Interventions: The Investigator will prescribe standard of care LABA to eligible study participants.
Participants will self-administer LABA once or twice daily

Date: 2023-02-24